Displaying drugs 12451 - 12475 of 13541 in total
N-Hydroxy-N-Isopropyloxamic Acid
Experimental
Matched Name: … N-Hydroxy-N-Isopropyloxamic Acid …
Matched Iupac: … [hydroxy(propan-2-yl)carbamoyl]formic acid …
Matched Iupac: … [hydroxy(propan-2-yl)carbamoyl]formic acid …
(P-Iodophenylacetylamino)Methylphosphinic Acid
Experimental
Matched Iupac: … {[2-(4-iodophenyl)acetamido]methyl}phosphinic acid …
3-phospho-D-glyceric acid
Experimental
Matched Synonyms: … 3-Phosphoglycerate ... 3-phospho-D-glycerate ... 3-Phospho-(R)-glycerate …
Matched Name: … 3-phospho-D-glyceric acid …
Matched Iupac: … (2R)-2-hydroxy-3-(phosphonooxy)propanoic acid …
Matched Name: … 3-phospho-D-glyceric acid …
Matched Iupac: … (2R)-2-hydroxy-3-(phosphonooxy)propanoic acid …
Chlorotoxin I-131
Chlorotoxin I-131 is investigated in clinical trials for treating brain cancer. Chlorotoxin I-131 binds to and reduces the activity of a matrix metalloproteinase (MMP) that regulates functioning of the chloride channels on cell membranes. Chlorotoxin is a small 36-amino-acid peptide that selectively binds to glioma cells but not normal brain...
Investigational
Matched Iupac: … {2-[4-(1,2-diphenylbutyl)phenoxy]ethyl}dimethylamine …
Matched Description: … It is a synthetic version of a neurotoxin isolated from the venom of the Giant Yellow Israeli scorpion ... Chlorotoxin I-131 binds to and reduces the activity of a matrix metalloproteinase (MMP) that regulates ... The synthetic version of this peptide has been manufactured and covalently linked to iodine 131 as a …
Matched Description: … It is a synthetic version of a neurotoxin isolated from the venom of the Giant Yellow Israeli scorpion ... Chlorotoxin I-131 binds to and reduces the activity of a matrix metalloproteinase (MMP) that regulates ... The synthetic version of this peptide has been manufactured and covalently linked to iodine 131 as a …
N-(ethoxycarbonyl)-L-leucine
Experimental
Matched Name: … N-(ethoxycarbonyl)-L-leucine …
Matched Iupac: … (2S)-2-[(ethoxycarbonyl)amino]-4-methylpentanoic acid …
Matched Iupac: … (2S)-2-[(ethoxycarbonyl)amino]-4-methylpentanoic acid …
1,1,1-TRIFLUORO-3-(OCTYLTHIO)ACETONE
Experimental
Matched Name: … 1,1,1-TRIFLUORO-3-(OCTYLTHIO)ACETONE …
Matched Iupac: … 1,1,1-trifluoro-3-(octylsulfanyl)propan-2-one …
Matched Iupac: … 1,1,1-trifluoro-3-(octylsulfanyl)propan-2-one …
Nisoxetine
Nisoxetine is a selective norepinephrine reuptake inhibitor (SNRI) developed in the 1970s. It was originally investigated as an antidepressant but has no current clinical applications aside from being a research standard SNRI. It has been used to research obesity and energy balance, and exerts some local analgesia effects.
Experimental
Matched Iupac: … [3-(2-methoxyphenoxy)-3-phenylpropyl](methyl)amine …
Matched Description: … Nisoxetine is a selective norepinephrine reuptake inhibitor (SNRI) developed in the 1970s. ... originally investigated as an antidepressant but has no current clinical applications aside from being a …
Matched Description: … Nisoxetine is a selective norepinephrine reuptake inhibitor (SNRI) developed in the 1970s. ... originally investigated as an antidepressant but has no current clinical applications aside from being a …
Tedatioxetine
Tedatioxetine has been used in trials studying the treatment of Major Depressive Disorder.
Investigational
Matched Iupac: … 4-{2-[(4-methylphenyl)sulfanyl]phenyl}piperidine …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Tributyrin
Tributyrin has been used in trials studying the treatment of Prostate Cancer and Unspecified Adult Solid Tumor, Protocol Specific.
Investigational
Matched Iupac: … 1,3-bis(butanoyloxy)propan-2-yl butanoate …
Acetylglycinamide chloral hydrate
Experimental
Matched Iupac: … 2,2,2-trichloroethane-1,1-diol; 2-acetamidoacetic acid …
Diclofop-methyl
Herbicide for control of wild oat & foxtails in cereal crops.
Experimental
Matched Iupac: … methyl 2-[4-(2,4-dichlorophenoxy)phenoxy]propanoate …
Ampreloxetine
Ampreloxetine is under investigation in clinical trial NCT03750552 (Clinical Effect of TD-9855 for Treating snOH in Subjects With Primary Autonomic Failure).
Investigational
Matched Iupac: … 4-{2-[(2,4,6-trifluorophenoxy)methyl]phenyl}piperidine …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
GED-0507-34-Levo
GED-0507-34-Levo is under investigation in clinical trial NCT02808390 (Efficacy and Safety Study of Ged-0507-34-levo for Treatment of UC).
Investigational
Matched Iupac: … (2S)-3-(4-aminophenyl)-2-methoxypropanoic acid …
Ghavamiol
Experimental
Matched Iupac: … {[(3R)-4-[(2R,3R,4R)-3,4-dihydroxy-2-(hydroxymethyl)pyrrolidin-1-yl]-1,3-dihydroxybutan-2-yl]oxy}-lambda4 …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
ISOTHIAZOLIDINONE ANALOG
Experimental
Matched Iupac: … (2S)-N-[(1S)-1-carbamoyl-2-{4-[(5S)-1,1,3-trioxo-1lambda6,2-thiazolidin-5-yl]phenyl}ethyl]-2-acetamido ... -3-phenylpropanamide …
Pexacerfont
Pexacerfont has been investigated for the treatment of Alcoholism, Anxiety Disorder, Alcohol Dependence, and Alcohol-Related Disorders.
Investigational
Matched Iupac: … N-[(2R)-butan-2-yl]-8-(6-methoxy-2-methylpyridin-3-yl)-2,7-dimethylpyrazolo[1,5-a][1,3,5]triazin-4-amine …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Upamostat
Upamostat has been used in trials studying the treatment of Pancreatic Cancer.
Investigational
Matched Iupac: … ethyl 4-[(2S)-3-{3-[(E)-N'-hydroxycarbamimidoyl]phenyl}-2-[2,4,6-tris(propan-2-yl)benzenesulfonamido] ... propanoyl]piperazine-1-carboxylate …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Technetium Tc-99m etifenin
Experimental
Matched Iupac: … 2-[(carboxymethyl)({[(2,6-diethylphenyl)carbamoyl]methyl})amino]acetic acid (98Tc)technetium 2-[(carboxylatomethyl …
Fencamfamin
Fencamfamin (Glucoenergan, Reactivan) is a stimulant which was developed in the 1960s as an appetite suppressant, but was later withdrawn for this application due to problems with dependence and abuse. It is around half the potency of dexamphetamine, and is prescribed at a dose of 10-60mg, although abusers of the...
Experimental
Illicit
Withdrawn
Matched Iupac: … N-ethyl-3-phenylbicyclo[2.2.1]heptan-2-amine …
Matched Description: … Fencamfamin (Glucoenergan, Reactivan) is a stimulant which was developed in the 1960s as an appetite ... It is around half the potency of [dexamphetamine], and is prescribed at a dose of 10-60mg, although abusers …
Matched Description: … Fencamfamin (Glucoenergan, Reactivan) is a stimulant which was developed in the 1960s as an appetite ... It is around half the potency of [dexamphetamine], and is prescribed at a dose of 10-60mg, although abusers …
Thiarsahydroxy-Cysteine
Experimental
Matched Iupac: … (2R)-2-amino-3-[(hydroxyarsanyl)sulfanyl]propanoic acid …
Displaying drugs 12451 - 12475 of 13541 in total